{"id":"W2953592136","doi":"10.1053/j.gastro.2019.06.038","title":"Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn’s Disease","year":2019,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":211,"is_retracted":false,"has_abstract":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"UCB Pharma; Janssen Pharmaceuticals; Ferring Research Institute; Sandoz; Bristol-Myers Squibb Canada; Ipsen; Tillotts Pharma; Ferring Pharmaceuticals; Shire; Novo Nordisk; Celltrion; Merck; United Soybean Board; Janssen Research and Development; UCB; Ironwood Pharmaceuticals, Incorporated; Regeneron Pharmaceuticals; Takeda Pharmaceutical Company; AbbVie; Janssen Biotech; Johnson and Johnson; Meso Scale Diagnostics; Teva Pharmaceutical Industries; Novartis; Celgene; Pfizer; Biogen; Gilead Sciences; Roche; Kyowa Hakko Kirin; Sanofi; GlaxoSmithKline; Genentech; Hospira; Atlantic Healthcare; ActoGeniX; Boehringer Ingelheim; Amgen; Allergan; Seres Therapeutics; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Vedolizumab; Medicine; Crohn's disease; Crohn disease; Endoscopy; Surgery; Disease; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005103825,0.0002307211,0.000594197,0.0007123061,0.0003739927,0.0006387697,0.0002230067,0.0005001497,0.0007840878],"category_scores_gemma":[0.002477457,0.0001990075,0.0005050511,0.000523144,0.0003066007,0.0005278174,0.0002347696,0.0005077253,0.0001135226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002424376,"about_ca_system_score_gemma":0.0001441192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00100184,"about_ca_topic_score_gemma":0.001472049,"domain_scores_codex":[0.9997062,0.00008535084,0.00004676314,0.00004189511,0.00006288229,0.00005691158],"domain_scores_gemma":[0.9991741,0.0002833179,0.0002579331,0.00003717329,0.00007286753,0.0001746988],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003219594,0.0001602848,0.9853359,0.00004637966,0.0001438885,0.001310464,0.0001096592,0.00007476633,0.001593225,0.00002742215,0.00009490821,0.007883374],"study_design_scores_gemma":[0.00006769243,0.000446734,0.9966803,0.0000130127,0.00009251928,0.001947487,0.000192509,0.0001770742,0.0001339288,0.00002690565,0.0002168628,0.000005018478],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973804,0.001598385,0.0000408873,0.00008180943,0.00001227142,0.000004816812,0.00004169023,0.00000256629,0.0008370397],"genre_scores_gemma":[0.9994662,0.0002885406,0.00003749156,0.00003373653,0.00002107374,0.000001899584,0.00006198172,9.534707e-7,0.00008800931],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00100184,"threshold_uncertainty_score":0.002699196,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.002883163305944709,"score_gpt":0.1841886992867892,"score_spread":0.1813055359808445,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}